Skip to main content
. 2011 Apr 5;5(6):404–408. doi: 10.1111/j.1750-2659.2011.00245.x

Table 1.

 Demographic characteristics of participants randomized to influenza vaccine or oseltamivir prophylaxis for the 2007–2008 influenza season in Toronto, Canada

Demographic variable Vaccine group
N = 12 (%*) Oseltamivir group
N = 42 (%*) P‐value
Median age (range) 41·3 years
(25–63 years) 40·6 years
(25–64 years) 0·80
Sex
 Female 9 (75) 28 (67) 0·73
Diagnosed with asthma 0 5 (12) 0·58
Current prescription medication 6 (50) 25 (60) 0·50
Influenza vaccine
 Not in past 3 years 0 7 (17)
 1 or 2 years 4 (33) 8 (19)
 All 3 years 8 (67) 25 (60) 0·30
Smoker (current) 1 (8) 9 (21) 0·29
Works in acute care 11 (92) 35 (83) 0·67
Direct patient care 6 (50) 19 (45) 0·77
Works in ED, ICU, or medical unit 7 (58) 16 (38) 0·32
Works with patients with ARI** 9 (75) 22 (52) 0·20
Works with children 1 (8) 1 (2) 0·35
Takes public transit for work or school commute 7 (58) 23 (55) 0·89
Household size
 1 person 2 (17) 6 (14)
 2 people 3 (25) 11 (26)
 3+ people 7 (58) 24 (57) 0·98
Child <2 years in home 2 (17) 1 (2) 0·12
Child in day care in home 3 (25) 5 (12) 0·36

ARI, acute respiratory illness; ED, emergency department; HCW, health care worker; ICU, intensive care unit.

*Of those responding to the question.

**Work that routinely brings the HCW into contact with patients who have ARI during winter cold or influenza season, including those with cough, influenza‐like illness or pneumonia.